Citation: M. Comer et al., CROSS-SPECIALTY VARIATION IN HEMATOLOGICAL DRUG-MONITORING - ARE RHEUMATOID (RA) PATIENTS MORE SUSCEPTIBLE TO ADVERSE REACTION, Arthritis and rheumatism, 41(9), 1998, pp. 1067-1067
Authors:
COMER M
JAMES IT
DCRUZ D
HUGHES GRV
PERRETT D
Citation: M. Comer et al., A NOVEL NON-RADIONUCLIDE ASSAY FOR ERYTHROCYTE THIOPURINE METHYLTRANSFERASE (TPMT) ACTIVITY - POTENTIAL FOR CLINICAL USE IN RHEUMATOLOGY, Arthritis and rheumatism, 41(9), 1998, pp. 1068-1068
Authors:
HANSEN HC
MORAN T
COMER M
DINGESS R
HOBBS A
Citation: Hc. Hansen et al., REDUCING ANESTHETIC COST PER CASE IN A RURAL-COMMUNITY HOSPITAL - A 2-YEAR EXPERIENCE, Anesthesiology, 89(3A), 1998, pp. 1336-1336
Authors:
DCRUZ D
CHESSER AMS
LIGHTOWLER C
COMER M
HURST MJ
BAKER LRI
RAINE AEG
Citation: D. Dcruz et al., ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-POSITIVE - CRESCENTIC GLOMERULONEPHRITIS ASSOCIATED WITH ANTITHYROID DRUG-TREATMENT, British journal of rheumatology, 34(11), 1995, pp. 1090-1091
Authors:
COMER M
SCOTT DL
DOYLE DV
HUSKISSON EC
HOPKINS A
Citation: M. Comer et al., ARE SLOW-ACTING ANTIRHEUMATIC DRUGS MONITORED TOO OFTEN - AN AUDIT OFCURRENT CLINICAL-PRACTICE, British journal of rheumatology, 34(10), 1995, pp. 966-970
Citation: Go. Storey et al., CHRONIC ARTHRITIS BEFORE 1876 - EARLY BRITISH CASES SUGGESTING RHEUMATOID-ARTHRITIS, Annals of the Rheumatic Diseases, 53(9), 1994, pp. 557-560